ArticleBMC infectious diseases2026
Bronchobiliary fistula secondary to hepatic malignancy with Exophiala dermatitidis infection: a case report.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchobiliary fistula (BBF) is a rare but severe complication following the treatment of hepatic malignancies. Exophiala Dermatitidis(E. Dermatitidis), a dematiaceous fungus, is an opportunistic pathogen that predominantly affects immunocompromised individuals. However, its role in BBF-associated infections has not been previously documented. CASE PRESENTATION: A 79-year-old man who was diagnosed with metastatic hepatic malignancy three years prior presented with a fever that persisted for seven days and dyspnoea for two days; a comprehensive evaluation was initiated on admission. Bronchoscopy revealed the presence of BBF, and imaging revealed hepatic and subphrenic abscesses. Ultrasound-guided drainage of the hepatic abscess was performed, and both the abscess aspirate and bronchoalveolar lavage fluid yielded E. dermatitidis on culture. Based on the clinical and microbiological findings, a diagnosis of BBF-related E. dermatitidis infection was established. The patient was treated with voriconazole (VRCZ) in conjunction with drainage. Antimicrobial therapy achieved the remission of symptoms, and the patient was discharged. Five months later, the disease recurred, necessitating readmission. Given the end-stage malignancy, profoundly poor performance status, and dismal prognosis, after exhaustive discussion, the family opted to forgo further active treatment.
conclusionsThis case highlights for the first time that BBF may serve as a unique conduit for the dissemination of E. dermatitidis, underscoring the importance of considering rare pathogens in patients with hepatic abscesses complicated by pulmonary infections. A prompt microbiological evaluation and targeted antifungal therapy are essential for optimal outcomes. CLINICAL TRIAL: This article is a case report; therefore, I declare that a clinical trial number is not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.